Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities

Journal of Lipid Research

Volumn 46, Issue 6, 2005, Pages 1239-1247

  Draganov, Dragomir I ^a   Teiber, John F ^a   Speelman, Audrey ^a   Osawa, Yoichi ^a   Sunahara, Roger ^a   La Du, Bert N ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Arylesterase; Low density lipoprotein oxidation; N acyl homoserine lactones; Protein expression and purification

Indexed keywords

ARACHIDONIC ACID; ARYLDIALKYLPHOSPHATASE 1; COPPER; HEXANOIC ACID; ICOSATETRAENOIC ACID; MANNOSE; MEVINOLIN; ORGANOPHOSPHATE; SPIRONOLACTONE; 5 HYDROXYICOSATETRAENOIC ACID; 5-HYDROXY-6,8,11,14-EICOSATETRAENOIC ACID; ARYLDIALKYLPHOSPHATASE; DOCOSAHEXAENOIC ACID; ESTERASE; HYDROXYICOSATETRAENOIC ACID; LACTONE; LOW DENSITY LIPOPROTEIN; OXYGEN; PON1 PROTEIN, HUMAN; PON2 PROTEIN, HUMAN; PON3 PROTEIN, HUMAN; RECOMBINANT PROTEIN;

ARTICLE; ENZYME ACTIVITY; ENZYME METABOLISM; ENZYME SPECIFICITY; GLYCOSYLATION; HUMAN; HUMAN CELL; HYDROLYSIS; IN VITRO STUDY; METABOLISM; OXIDATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; CELL LINE; CHEMISTRY; GENE EXPRESSION REGULATION; KINETICS; LIVER; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; TIME; WESTERN BLOTTING;

ARYLDIALKYLPHOSPHATASE; BLOTTING, WESTERN; CELL LINE; COPPER; DOCOSAHEXAENOIC ACIDS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESTERASES; GENE EXPRESSION REGULATION; GLYCOSYLATION; HUMANS; HYDROLYSIS; HYDROXYEICOSATETRAENOIC ACIDS; KINETICS; LACTONES; LIPOPROTEINS, LDL; LIVER; MANNOSE; OXYGEN; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY; TIME FACTORS;

EID: 21244491480     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M400511-JLR200     Document Type: Article

References (58)

1. Primo-Parmo, S. L., R. C. Sorenson, J. Teiber, and B. N. La Du. 1996. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics. 33: 498-507.
2. La Du, B. N., M. Aviram, S. Billecke, M. Navab, S. Primo-Parmo, R. C. Sorenson, and T. J. Standiford. 1999. On the physiological role(s) of the paraoxonases. Chem. Biol. Interact. 119-120: 379-388.
3. Draganov, D. I., and B. N. La Du. 2004. Pharmacogenetics of paraoxonases: a brief review. Naunyn-Schmiedeberg's Arch. Pharmacol. 369: 78-88.
4. La Du, B. N. 1992. Human serum paraoxonase/arylesterase. In Genetic Factors Influencing the Metabolism of Foreign Compounds: International Encyclopedia of Pharmacology and Therapeutics. W. Kalow, editor. Pergamon Press, New York. 51-91.
5. Davies, H. G., R. J. Richter, M. Keifer, C. A. Broomfield, J. Sowalla, and C. E. Furlong. 1996. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat. Genet. 14: 334-336.
6. Broomfield, C. A., and K. W. Ford. 1991. Hydrolysis of nerve gases by plasma enzymes. In Proceedings of the 3rd International Meeting on Cholinesterases, La Grande-Motte, France. 161.
7. Billecke, S., D. Draganov, R. Counsell, P. Stetson, C. Watson, C. Hsu, and B. N. La Du. 2000. Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters. Drug Metab. Dispos. 28: 1335-1342.
8. Biggadike, K., R. M. Angell, C. M. Burgess, R. M. Farrell, A. P. Hancock, A. J. Harker, W. R. Irving, C. Ioannou, P. A. Procopiou, R. E. Shaw, et al. 2000. Selective plasma hydrolysis of glucocorticoid gamma-lactones and cyclic carbonates by the enzyme paraoxonase: an ideal plasma inactivation mechanism. J. Med. Chem. 43: 19-21.
9. Teiber, J. F., D. I. Draganov, and B. N. La Du. 2003. Lactonase and lactonizing activities of human paraoxonase (PON1) and rabbit serum PON3. Biochem. Pharmacol. 66: 887-896.
10. Draganov, D. I., P. L. Stetson, C. E. Watson, S. S. Billecke, and B. N. La Du. 2000. Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation. J. Biol. Chem. 275: 33435-33442.
11. Rodrigo, L., F. Gil, A. F. Hernandez, O. Lopez, and A. Pla. 2003. Identification of paraoxonase 3 in rat liver microsomes. Purification and biochemical properties. Biochem. J. 376: 261-268.
12. Rosenblat, M., D. Draganov, C. E. Watson, C. L. Bisgaier, B. N. La Du, and M. Aviram. 2003. Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraoxonase 3 activity is decreased under oxidative stress. Arterioscler. Thromb. Vasc. Biol. 23: 468-474.
13. Mackness, M. I. 1989. Possible medical significance of human serum 'A-' esterases. In Enzymes Hydrolysing Organophosphorus Compounds. E. Rainer, W. N. Aldridge, and F. C. G. Hoskin, editors. Ellis Horwood, Chichester, UK. 202-213.
14. Hassett, C., R. J. Richter, R. Humbert, C. Chapline, J. W. Crabb, C. J. Omiecinski, and C. E. Furlong. 1991. Characterization of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence. Biochemistry. 30: 10141-10149.
15. Sorenson, R. C., C. L. Bisgaier, M. Aviram, C. Hsu, S. Billecke, and B. N. La Du. 1999. Human serum paraoxonase/arylesterase's retained hydrophobic N-terminal leader sequence associates with high density lipoproteins by binding phospholipids: apolipoprotein A-1 stabilizes activity. Arterioscler. Thromb. Vasc. Biol. 19: 2214-2225.
16. Reddy, S. T., D. J. Wadleigh, V. Grijalva, C. Ng, S. Hama, A. Gangopadhyay, D. M. Shih, A. J. Lusis, M. Navab, and A. M. Fogelman. 2001. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler. Thromb. Vasc. Biol. 21: 542-547.
17. Ng, C. J., D. J. Wadleigh, A. Gangopadhyay, S. Hama, V. R. Grijalva, M. Navab, A. M. Fogelman, and S. T. Reddy. 2001. Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J. Biol. Chem. 276: 44444-44449.
18. Mochizuki, H., S. W. Scherer, T. Xi, D. C. Nickle, M. Majer, J. J. Huizenga, L. C. Tsui, and M. Prochazka. 1998. Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence. Gene. 213: 149-157.
19. Mackness, M. I., S. Arrol, and P. N. Durrington. 1991. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett. 286: 152-154.
20. Aviram, M., M. Rosenblat, C. L. Bisgaier, R. S. Newton, S. L. Primo-Parmo, and B. N. La Du. 1998. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J. Clin. Invest. 101: 1581-1590.
21. Aviram, M., M. Rosenblat, S. Billecke, J. Erogul, R. Sorenson, C. L. Bisgaier, R. S. Newton, and B. La Du. 1999. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic. Biol. Med. 26: 892-904.
22. Watson, A. D., J. A. Berliner, S. Y. Hama, B. N. La Du, K. F. Faull, A. M. Fogelman, and M. Navab. 1995. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin. Invest. 96: 2882-2891.
23. Durrington, P. N., B. Mackness, and M. I. Mackness. 2001. Paraoxonase and atherosclerosis. Arteriosler. Thromb. Vasc. Biol. 21: 473-480.
24. Costa, L. G., T. B. Cole, G. P. Jarvik, and C. E. Furlong. 2003. Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. Annu. Rev. Med. 54: 371-392.
25. Shih, D. M., L. Gu, Y. R. Xia, M. Navab, W. F. Li, S. Hama, L. W. Castellani, C. E. Furlong, L. G. Costa, and A. M. Fogelman. 1998. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature. 394: 284-287.
26. Shih, D. M., S. T. Reddy, and A. J. Lusis. 2002. CHD and atherosclerosis: human epidemiological studies and transgenic mouse models. In Paraoxonase (PON1) in Health and Disease. L. G. Costa and C. E. Furlong, editors. Kluwer Academic Publishers, Norwell, MA. 93-124.
27. Brushia, R. J., T. M. Forte, M. N. Oda, B. N. La Du, and J. K. Bielicki. 2001. Baculovirus-mediated expression and purification of human serum paraoxonase 1A. J. Lipid Res. 42: 951-958.
28. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227: 680-685.
29. Ferguson, K. A. 1964. Starch-gel electrophoresis - application to the classification of pituitary proteins and polypeptides. Metabolism. 13: 985-1002.
30. Bryan, J. K. 1977. Molecular weights of protein multimers from polyacrylamide gel electrophoresis. Anal. Biochem. 78: 513-519.
31. Kuo, C. L. and B. N. La Du. 1995. Comparison of purified human and rabbit serum paraoxonases. Drug Metab. Dispos. 23: 935-944.
32. Eckerson, H. W., C. M. Wyte, and B. N. La Du. 1983. The human serum paraoxonase/arylesterase polymorphism. Am. J. Hum. Genet. 35: 1126-1138.
33. Furlong, C. E., R. J. Richter, S. L. Seidel, L. G. Costa, and A. G. Motulsky. 1989. Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/ arylesterase. Anal. Biochem. 180: 242-247.
34. Kingston, R. E. 1993. Introduction of DNA into mammalian cells. In Current Protocols in Molecular Biology. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl, editors. John Wiley & Sons, New York. 9.1.1-9.1.7.
35. Teiber, J. F., D. I. Draganov, and B. N. La Du. 2004. Serum PON1 does not protect LDL against oxidation induced by copper and AAPH in vitro. J. Lipid Res. 45: 2260-2268.
36. Kuo, C. L., and B. N. La Du. 1998. Calcium binding by human and rabbit serum paraoxonases. Structural stability and enzymatic activity. Drug Metab. Dispos. 26: 653-660.
37. Pearson, J. P., L. Passador, B. H. Iglewski, and E. P. Greenberg. 1995. A second N-acylhomoserine lactone signal produced by Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA. 92: 1490-1494.
38. Rodrigo, L., B. Mackness, P. N. Durrington, A. Hernandez, and M. I. Mackness. 2001. Hydrolysis of platelet-activating factor by human serum paraoxonase. Biochem. J. 354: 1-7.
39. Ahmed, Z., A. Ravandi, G. F. Maguire, A. Emili, D. Draganov, B. N. La Du, A. Kukis, and P. W. Connelly. 2002. Multiple substrates for paraoxonase-1 during oxidation of phosphatidylcholine by peroxynitrite. Biochem. Biophys. Res. Commun. 290: 3937-3947.
40. Connelly, P. W., D. Draganov, and G. F. Maguire. 2005. Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite. Free Radic. Biol. Med. 38: 164-174.
41. Marathe, G. K., G. A. Zimmerman, and T. M. McIntyre. 2003. Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles. J. Biol. Chem. 278: 3937-3947.
42. Kobayashi, M., M. Shinohara, C. Sakoh, M. Kataoka, and S. Shimizu. 1999. Lactone-ring-cleaving enzyme: genetic analysis, novel RNA editing, and evolutionary implications. Proc. Natl. Acad. Sci. USA. 95: 2787-2792.
43. Saeed, S. A., and M. D. Mitchell. 1983. Lipoxygenase activity in human uterine and intrauterine tissues: new prospects for control of prostacyclin production in pre-eclampsia. Clin. Exp. Hypertens. B. 2: 103-111.
44. Schulam, P. G., and W. T. Shearer. 1990. Evidence for 5-lipoxygenase activity in human B cell lines. A possible role for arachidonic acid metabolites during B cell signal transduction. J. Immunol. 144: 2696-2701.
45. Haviv, F., J. D. Ratajczyk, R. W. DeNet, Y. C. Martin, R. D. Dyer, and G. W. Carter. 1987. Structural requirements for the inhibition of 5-lipoxygenase by 15-hydroxyeicosa-5,8,11,13-tetraenoic acid analogues. J. Med. Chem. 30: 254-263.
46. Kerdesky, F. A. J., S. P. Schmidt, J. H. Holms, R. D. Dyer, G. W. Carter, and D. W. Brooks. 1987. Synthesis and 5-lipoxygenase inhibitory activity of 5-hydroperoxy-6,8,11,14-eicosatetraenoic acid analogs. J. Med. Chem. 30: 1177-1186.
47. Chang, J., B. Lamb, L. Marinari, A. F. Kreft, and A. J. Lewis. 1985. Modulation by hydroxyeicosatetraenoic acids (HETEs) of arachidonic acid metabolism in mouse resident peritoneal macrophages. Eur. J. Pharmacol. 107: 215-222.
48. Chang, J., E. Blazek, A. F. Kreft, and A. J. Lewis. 1985. Inhibition of platelet and neutrophil phospholipase A2 by hydroxyeicosatetraenoic acids (HETES). A novel pharmacological mechanism for regulating free fatty acid release. Biochem. Pharmacol. 34: 1571-1575.
49. Dugrillon, A. 1996. Iodolactones and iodoaldehydes - mediators of iodine in thyroid autoregulation. Exp. Clin. Endocrinol. Diabetes. 104 (Suppl. 4): 41-45.
50. Serhan, C. N., K. Gotlinger, S. Hong, and M. Arita. 2004. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. Prostaglandins Other Lipid Mediat. 73: 155-172.
51. Kieran, N. E., P. Maderna, and C. Godson. 2004. Lipoxins: potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease. Kidney Int. 65: 1145-1154.
52. Fulton, D., J. R. Falck, J. C. McGiff, M. A. Carroll, and J. Quilley. 1998. A method for the determination of 5,6-EET using the lactone as an intermediate in the formation of the diol. J. Lipid Res. 39: 1713-1721.
53. Oltman, C. L., N. L. Weintraub, M. VanRollins, and K. C. Dellsperger. 1998. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation. Circ. Res. 83: 932-939.
54. Roche, D. M., J. T. Byers, D. S. Smith, F. G. Glansdorp, D. R. Spring, and M. Welch. 2004. Communication blackout? Do N-acylhomoserine-lactone- degrading enzymes have any role in quorum sensing? Microbiology. 150: 2023-2028.
55. Tateda, K., Y. Ishii, M. Horikawa, T. Matsumoto, S. Miyairi, J. C. Pechere, T. J. Standiford, M. Ishiguro, and K. Yamaguchi. 2003. The Pseudomonas aeruginosa autoinducer N-3-oxododecanoyl homoserine lactone accelerates apoptosis in macrophages and neutrophils. Infect. Immun. 71: 5785-5793.
56. Hooi, D. S. W., B. W. Bycroft, S. R. Chhabra, P. Williams, and D. I. Pritchard. 2004. Differential immune modulatory activity of Pseudomonas aeruginosa quorum-sensing signal molecules. Infect. Immun. 72: 6463-6470.
57. Chun, C. K., E. A. Ozer, M. J. Welsh, J. Zabner, and E. P. Greenberg. 2004. Inactivation of a Pseudomonas aeruginosa quorum-sensing signal by human airway epithelia. Proc. Natl. Acad. Sci. USA. 101: 3587-3590.
58. Harel, M., A. Aharoni, L. Gaidukov, B. Brumshtein, O. Khersonsky, R. Meged, H. Dvir, R. B. G. Ravelly, A. McCarthy, L. Toker, et al. 2004. Structure and evolution of the serum paraoxonase family of detoxifying and antiatherosclerotic enzymes. Nat. Struct. Mol. Biol. 11: 412-419.